Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses Protein A ligands, which serve as the key binding elements within Protein A affinity chromatography resins, as well as specialized cell culture growth factors. In the realm of chromatography, Repligen offers a range of products: Its OPUS line features pre-packed chromatography columns, instrumental in purifying biologics, alongside smaller-scale OPUS columns designed for high-throughput process development screening, viral clearance validation studies, and the scaling-down of chromatography processes. Additionally, the company supplies ELISA test kits and chromatography resins marketed under the CaptivA brand. Repligen also boasts an extensive suite of filtration products. This includes XCell Alternating Tangential Flow systems, which are filtration devices utilized in upstream perfusion and cell culture processing. For downstream applications like biologic drug concentration and formulation, they provide TangenX flat sheet cassettes. Other filtration offerings encompass KrosFlo tangential flow filtration and tangential flow depth filtration systems, Spectra/Por laboratory and process dialysis products, SpectraFlo dynamic dialysis systems, and ProConnex single-use hollow fibers. Furthermore, Repligen addresses process analytics with its slope spectroscopy systems, branded as SoloVPE, FlowVPE, and FlowVPX. Their clientele is broad, consisting of life sciences organizations, biopharmaceutical and diagnostics companies, laboratory researchers, and contract manufacturing organizations. Repligen also collaborates with partners, such as Navigo Proteins GmbH, on the development of various affinity ligands. The corporation was founded in 1981 and maintains its corporate headquarters in Waltham, Massachusetts.
The current price of RGEN is $131.11 USD — it has increased by +0.4% in the past 24 hours. Watch Repligen stock price performance more closely on the chart.
What is Repligen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Repligen stocks are traded under the ticker RGEN.
Is Repligen stock price growing?▼
RGEN stock has risen by +4.38% compared to the previous week, the month change is a +27.17% rise, over the last year Repligen has showed a +2.59% increase.
What is Repligen market cap?▼
Today Repligen has the market capitalization of 7.39B
When is the next Repligen earnings date?▼
Repligen is going to release the next earnings report on August 04, 2026.
What were Repligen earnings last quarter?▼
RGEN earnings for the last quarter are 0.48 USD per share, whereas the estimation was 0.38 USD resulting in a +24.97% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Repligen revenue for the last year?▼
Repligen revenue for the last year amounts to 1.48B USD.
What is Repligen net income for the last year?▼
RGEN net income for the last year is 97.79M USD.
How many employees does Repligen have?▼
As of June 15, 2026, the company has 1,778 employees.
In which sector is Repligen located?▼
Repligen operates in the Health & Wellness sector.
When did Repligen complete a stock split?▼
Repligen has not had any recent stock splits.
Where is Repligen headquartered?▼
Repligen is headquartered in Waltham, United States.